Identify Dairy
Natural health product licensed in Canada
- Licence holder
- Enzyme Science
- NPN or DIN-HM
- 80037248
- Status
- Active licence
- Licence date
- 7 November 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 29,360 FCC HUT | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 37 mg | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 29,360 FCC HUT | Not calculated |
| Protéase fongique Source : Aspergillus niger - En entier | 37 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 7,500 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 75 mg | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - cellule entière | 25 FCC SU | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - cellule entière | 1 mg | Not calculated |
| Protéase bactérien Source : Bacillus subtilis - cellule entière | 1,007 FCC PC | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 50 FCC GalU | Not calculated |
| Diastase du malt Source : Aspergillus niger - En entier | 350 FCC DP° | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 1,000 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 6 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 1,000 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 6 mg | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 25 Unité de glucoamylase du FCC | Not calculated |
| 4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 25 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Eau distillée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzymes. Protease is a digestive aid. Protease helps digest proteins. Lactase to assist in the digestion of foods containing lactose (e.g. dairy foods, milk). Helps prevent the symptoms of lactose intolerance (including gas, bloating, cramping, and diarrhea).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80037248
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.